FVCM
VIVS

F&V Capital Management’s VivoSim Labs VIVS Stock Holding History

F&V Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-47
Closed -$125K – 64
2013
Q4 		$125K Sell
47
-21
-31% -$41.2K 0.1% 58
2013
Q3 		$93K Buy
+68
New +$95K 0.08% 63

Other funds holding VIVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

F&V Capital Management's VIVS Position: Q1 2014 in Review

F&V Capital Management sold out of VivoSim Labs (VIVS) in Q1 2014, closing a stake of 47 shares — an estimated $125K sold.

F&V Capital Management first reported a position in VIVS in Q3 2013 and held it in 2 quarters. The position peaked at $125K in Q4 2013. 94 funds tracked by Wall St. Rank hold VIVS as of Q1 2014.

  • F&V Capital Management reported no remaining VivoSim Labs position as of Q1 2014 after selling out during the quarter.
  • F&V Capital Management sold 47 VivoSim Labs shares in Q1 2014, an estimated $125K.
  • F&V Capital Management first reported a position in VivoSim Labs in Q3 2013 and held it in 2 quarters.
  • F&V Capital Management's VivoSim Labs position peaked at $125K in Q4 2013.
  • 94 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2014.

Based on F&V Capital Management's 13F filing for Q1 2014, filed 10 Apr 2014.